Insider Zero‑Cost Option Buys Signal Confidence in ImmuCell’s Growth Outlook
Zero‑cost insider option exercises at ImmuCell signal confidence in rising milk‑derived antibody demand, hinting at potential upside for investors.
3 minutes to read
ImmuCell Corp